Sun Pharma Clarifies News Report on Assam Facility and Share Price Movement
Sun Pharmaceutical Industries Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 2:28 am
Sun Pharma Clarifies News Report on Assam Facility and Share Price Movement Sun Pharmaceutical Industries clarified that news reports regarding halted eye-care drug production at its Assam facility stem from developments in Aug'26 rather than any new event on 30th Oct'26. The company noted the matter did not warrant a Regulation 30 disclosure when assessed. Sun Pharma also stated it cannot attribute recent share price fluctuations to the report or any specific factor, noting Q2/H1 FY27 financial results were announced on 30th Oct'26, and confirmed no undisclosed material events exist.
Original exchange filing (PDF)
More announcements from Sun Pharmaceutical Industries Ltd
- Intimation of Schedule of Analyst/Institutional Investor Meeting 路 05 Nov 2026
- Q2FY27 Earnings Call Transcript 路 05 Nov 2026
- The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting .... 路 02 Nov 2026
- Completion and results of postal ballot dated 01 October 2026 路 01 Nov 2026
- Q2FY27- Investor Call Audio Recording 路 31 Oct 2026
- Board Meeting Outcome - Conclusion 路 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
